Ranitidine (State of Florida DOH Central Pharmacy)


Welcome to the PulseAid listing for the Ranitidine drug offered from State of Florida DOH Central Pharmacy. This Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: State of Florida DOH Central Pharmacy
NON-PROPRIETARY NAME: Ranitidine
SUBSTANCE NAME: RANITIDINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2009-07-01
END MARKETING DATE: 0000-00-00


Ranitidine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRanitidine from State of Florida DOH Central Pharmacy
LABELER NAME: State of Florida DOH Central Pharmacy
DEA SCHEDULE:
ACTIVE STRENGTH: 150(mg/1)
START MARKETING DATE: 2009-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 53808-0774_8ec6d8b3-9152-4154-91ea-48ab5bfd1968
PRODUCT NDC: 53808-0774
APPLICATION NUMBER: ANDA075180

Other RANITIDINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
ATLANTIC BIOLOGICALS CORP.Ranitidine
McKesson Packaging Services Business Unit of McKesson CorporationRanitidine
Pharmaceutical Associates, Inc.Ranitidine
Sandoz Inc.Ranitidine
State of Florida DOH Central PharmacyRanitidine